WHO世界卫生组织：2026年关于在布迪布戈病毒病暴发期间使用获准的埃博拉病毒疫苗的紧急指南报告（英文版）

This emergency guidance document outlines the World Health Organization (WHO) position on the use of the licensed Ebola virus vaccine Ervebo® during outbreaks of Bundibugyo virus disease (BVD) caused by Bundibugyo virus (BDBV). Issued in the context of the 2026 Public Health Emergency of International Concern, the document reviews available evidence regarding potential cross-protection of Ervebo®, which is licensed for Ebola virus disease caused by Ebola virus (EBOV), against BDBV infection.